Radiopharm Theranostics Limited (ASX:RAD – Get Free Report) insider Paul Hopper sold 1,500,000 shares of Radiopharm Theranostics stock in a transaction on Thursday, December 5th. The stock was sold at an average price of A$0.03 ($0.02), for a total value of A$43,500.00 ($27,707.01).
Radiopharm Theranostics Price Performance
About Radiopharm Theranostics
Radiopharm Theranostics Limited engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical needs. It is developing its lead products comprising Nano-mAbs and AVB6 Integrin. The company was incorporated in 2021 and is based in Carlton, Australia.
Featured Articles
- Five stocks we like better than Radiopharm Theranostics
- What is a SEC Filing?
- 3 Consumer Discretionary Stocks Ready for a Comeback in 2025
- Best Stocks Under $10.00
- Top 3 Robotics and Automation Stocks for the Next AI Boom
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Why a Stock Split Could Be a Game-Changer for Casey’s in 2025
Receive News & Ratings for Radiopharm Theranostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Radiopharm Theranostics and related companies with MarketBeat.com's FREE daily email newsletter.
